Diligence memo · auto-generated · as of July 2, 2026
Enable Injections, Inc
Enable Injections, Inc has raised $245M over 9 rounds; too few niche peers to rank its valuation yet.
Businessfiled
Enable Injections, Inc operates in Other Health Care, based in CINCINNATI.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Enable Injections, Inc has raised $245M in disclosed capital across 9 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $150M on 2022-01-27.
Most recent recorded round closed around 2025-12-29.
Valuation (modeled)modeled
Provath models Enable Injections, Inc at approximately $222M (range $160M–$260M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 6 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round was 5.0× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 89% of those peers.
Closest niche peers: VeraDermics, Inc, Wugen, Inc., HeartFlow Holding, Inc..
Peoplefiled
24 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.